📋1. OVERVIEW & PROTOCOL

• Wolverine Blemd Structure: This research vial contains a pre-formulated dual blend combining BPC-157 and TB-500, two synthetic peptides featuring distinct molecular pathways and complementary signaling profiles.
• Biological Focus: Formulated to explore concurrent peptide-mediated networks, evaluating combined structural tissue remodeling, angiogenesis mechanism profiling, and cytoskeletal binding interactions.
• Cellular Intensity: In-vitro testing monitors VEGFR2-, FAK-, and eNOS-associated signaling networks alongside actin polymerization dynamics via the highly conserved LKKTET binding motif.

🧪2. CHEMICAL PROPERTIES

• Chemical Formulas: BPC-157 (C62H98N16O22) / TB-500 (C212H350N56O78S)
• Molecular Molar Mass: BPC-157: 1419.5 g/mol / TB-500: 4693.4 g/mol
• CAS Numbers Reference: 137525-51-0 | 77591-33-4
• PubChem CID Profiles: 9941957 | 16132341
• Reconstitution Purity: Lyophilized freeze-dried preparation manufactured to remain as separate, chemically distinct components within a single solution without forming covalent conjugates.
• Storage Stability: Shelf life certified for 36 months when stored under optimized, controlled clinical laboratory environments.

🔬3. AUDITED RESEARCH & SPECIFICATIONS

• Stability Advantage: Meticulously co-formulated to reduce reconstitution complexity in multi-peptide study designs, preserving the individual pharmacological profile of each molecular identity.
• Signaling Pathways: Focused on comparative evaluation of cell-motility networks, monomeric G-actin sequestration, and structural protein organization cascades.
• Regulatory Safety Notice: This blend vial is a characterized reference substance supplied strictly for laboratory research and clinical in-vitro evaluation only. Not approved for human consumption.